SHIRE PHARMACEUTICALS MBC
- As Shire expands in Lexington, its merger target earns a key drug approval Bizjournals Health Care
- Shire to buy NPS for $5.2 billion to boost rare disease drugs Reuters - Top News
- PRESS DIGEST- New York Times business news - Jan 12 Fidelity - Merger and Acquision News
- <b>Shire</b> May Spend AbbVie Breakup Fee On NPS Pharmaceuticals, Inc.; <b>NPS</b> Surges On Rumor Bio Space - All News
- CEO who oversaw ViroPharma sale named to same role at Idera The Boston Business Journal - Local News - Boston, MA
- Shire relocates jobs to Massachusetts Fresno Bee California
- AbbVie, Shire agree to end $52-billion deal The Los Angeles Times - Business - Los Angeles, CA
- Shire Loses CFO Following Failed $55B AbbVie Merger Law 360 Corporate Finance
- The AbbVie-Shire breakup is an erosion of trust ... and ironic (Video) Journal of New England Technology
- $54 billion AbbVie-Shire deal appears to be dying The Philadelphia Inquirer - Philadelphia, PA
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on SHIRE PHARMACEUTICALS MBC
- Rate SHIRE PHARMACEUTICALS MBC on their payment behavior
- Ask your network about SHIRE PHARMACEUTICALS MBC with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.